- One Health
- Pain Management
- Oncology
- Geriatric & Palliative Medicine
- Ophthalmology
- Anatomic Pathology
- Poultry Medicine
- Infectious Diseases
- Dermatology
- Theriogenology
- Nutrition
- Animal Welfare
- Radiology
- Internal Medicine
- Small Ruminant
- Cardiology
- Dentistry
- Feline Medicine
- Soft Tissue Surgery
- Urology/Nephrology
- Avian & Exotic
- Preventive Medicine
- Anesthesiology & Pain Management
- Integrative & Holistic Medicine
- Food Animals
- Behavior
- Zoo Medicine
- Toxicology
- Orthopedics
- Emergency & Critical Care
- Equine Medicine
- Pharmacology
- Pediatrics
- Respiratory Medicine
- Shelter Medicine
- Parasitology
- Clinical Pathology
- Virtual Care
- Rehabilitation
- Epidemiology
- Fish Medicine
- Diabetes
- Livestock
- Endocrinology
USP changes are here: what every veterinary professional needs to know
Recently updated USP standards and how they impact compounding medicines for veterinary practitioners
Subscribe to The Vet Blast Podcast on Apple Podcasts, Spotify, or wherever you get your podcasts.
In the veterinary industry, the recent United States Pharmacopeia (USP) updates pose the question: How will compounding medicines be affected?
In this episode, Marcy A. Bliss and Anthony Grzib, R.Ph., share their insights surrounding the USP revisions and how they may affect veterinarians, including the basics of the updated practice standards highlighted in USP General Chapters <795> and <797>.
Below is a partial transcript. Listen to the podcast above for more.
Anthony Grzib, R.Ph.: “USP [bases its] standards on science and evidence. For the most part, these standards in the revised chapters are more rigorous than we’ve seen in the past…The two areas that I think are the most impactful to both pharmacies and veterinarians have to do with the assigning of beyond-use dates.”
